PharmCADD is a company designed to accelerate drug discovery meanwhile performing a design without building or maintaining the infrastructure associated with high-performance computational resources. The platform for both the design and discovery in the PharmCADD is composed of the state-of-the art technology: AI (Artificial intelligence), Molecular Dynamics (MD), Quantum Calculation (QC), and Network theory.
AI, which is data-derived technology emerges as a new trend which could potentially be very revolutionary in our modern world. It enables customers to accelerate the search for a certain or specific drug candidate in the vast existence of chemical space.
On the other hand, MD and quantum calculation, physics-based technology, enables the customers to characterize potential drug candidates more precisely. The effective combination of the data-derived and physics-based technologies leads to more accurate and speedier drug discovery.
Company Details
- Employees
- 17
- Address
- 17, Apec-Ro, U-Dong, Haeundae-Gu, 221,222 Ho,korea, Republic Of
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- pharmcadd.com
- Keywords
- Atomicas.
- HQ
- Busan
Pharmcadd Questions
Pharmcadd's website is pharmcadd.com
Pharmcadd's LinkedIn profile is https://kr.linkedin.com/company/pharmcadd
Pharmcadd has
17 employees.
View email and phone details for 17
employees at Pharmcadd.
Pharmcadd's industry is
Biotechnology Research
Pharmcadd's top competitors are
Biocogniz,
Boltzmann Labs,
Prescience Insilico,
Molecular Forecaster,
Quantumzyme,
Torx® Software,
Sai Life Sciences Ltd,
Atomicas,
Cresset,
Rasa Life Science Informatics.
Pharmcadd's categories are Biotechnology Research
